These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


177 related items for PubMed ID: 2433654

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Comparison of the effects of fermented and unfermented mistletoe preparations on cultured tumor cells.
    Ribéreau-Gayon G, Jung ML, Di Scala D, Beck JP.
    Oncology; 1986; 43 Suppl 1():35-41. PubMed ID: 3808575
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Improvement of DNA repair in lymphocytes of breast cancer patients treated with Viscum album extract (Iscador).
    Kovacs E, Hajto T, Hostanska K.
    Eur J Cancer; 1991; 27(12):1672-6. PubMed ID: 1782081
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Donor-dependent and dose-dependent variation in the induction of T lymphocyte locomotion in a three-dimensional collagen matrix system by a mistletoe preparation (Iscador).
    Nikolai G, Friedl P, Werner M, Zänker KS.
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S61-4. PubMed ID: 9179371
    [Abstract] [Full Text] [Related]

  • 34. Anticarcinogenic and antimetastatic activity of Iscador.
    Kuttan G, Menon LG, Antony S, Kuttan R.
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S15-6. PubMed ID: 9179361
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Characterization of a toxic lectin in Iscador, a mistletoe preparation with alleged cancerostatic properties.
    Holtskog R, Sandvig K, Olsnes S.
    Oncology; 1988 Apr; 45(3):172-9. PubMed ID: 3368193
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Prospective controlled cohort studies on long-term therapy of ovairian cancer patients with mistletoe (Viscum album L.) extracts iscador.
    Grossarth-Maticek R, Ziegler R.
    Arzneimittelforschung; 2007 Apr; 57(10):665-78. PubMed ID: 18074761
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Pleura carcinosis. Cytomorphological findings with the mistletoe preparation iscador and other pharmaceuticals.
    Salzer G.
    Oncology; 1986 Apr; 43 Suppl 1():66-70. PubMed ID: 3808576
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.